Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 1.15 trillion. The enterprise value is 1.11 trillion.

Market Cap	1.15T
Enterprise Value	1.11T

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	94.00M

Valuation Ratios

The trailing PE ratio is 54.58.

PE Ratio	54.58
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	12.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.31, with an EV/FCF ratio of 55.73.

EV / Earnings	52.68
EV / Sales	10.11
EV / EBITDA	39.31
EV / EBIT	46.13
EV / FCF	55.73

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.04.

Current Ratio	2.95
Quick Ratio	2.07
Debt / Equity	0.04
Debt / EBITDA	0.17
Debt / FCF	0.24
Interest Coverage	75.89

Financial Efficiency

Return on equity (ROE) is 22.02% and return on invested capital (ROIC) is 14.95%.

Return on Equity (ROE)	22.02%
Return on Assets (ROA)	11.97%
Return on Capital (ROIC)	14.95%
Revenue Per Employee	5.64M
Profits Per Employee	1.08M
Employee Count	19,540
Asset Turnover	0.88
Inventory Turnover	2.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+45.25%
50-Day Moving Average	2,663.18
200-Day Moving Average	2,377.90
Relative Strength Index (RSI)	60.31
Average Volume (20 Days)	17,175

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 110.18 billion and earned 21.15 billion in profits. Earnings per share was 52.70.

Revenue	110.18B
Gross Profit	76.55B
Operating Income	24.02B
Pretax Income	26.51B
Net Income	21.15B
EBITDA	28.16B
EBIT	24.02B
Earnings Per Share (EPS)	52.70

Full Income Statement

Balance Sheet

The company has 47.27 billion in cash and 4.82 billion in debt, giving a net cash position of 42.45 billion.

Cash & Cash Equivalents	47.27B
Total Debt	4.82B
Net Cash	42.45B
Net Cash Per Share	n/a
Equity (Book Value)	107.89B
Book Value Per Share	263.72
Working Capital	56.43B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.23 billion and capital expenditures -3.24 billion, giving a free cash flow of 19.99 billion.

Operating Cash Flow	23.23B
Capital Expenditures	-3.24B
Free Cash Flow	19.99B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.47%, with operating and profit margins of 21.80% and 19.20%.

Gross Margin	69.47%
Operating Margin	21.80%
Pretax Margin	24.06%
Profit Margin	19.20%
EBITDA Margin	25.56%
EBIT Margin	21.80%
FCF Margin	18.15%

Dividends & Yields

Mankind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	1.83%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mankind Pharma has an Altman Z-Score of 19.

Altman Z-Score	19
Piotroski F-Score	n/a